Medicare Claims Sensitivity Low for Tumor Detection and Incomplete Colonoscopy

Researchers caution GI physicians when using Medicare claims data for important quality measures, in particular tumor detection and incomplete colonoscopy, as research results showed Medicare claims have low sensitivity for those diagnoses, according to a study published in Gastrointestinal Endoscopy.

Advertisement

A team of researchers conducted a cross-sectional study of patients aged 65 and older undergoing colonoscopy. Patients’ colonoscopy records were linked to Medicare colonoscopy claims by patients’ age, sex, date of procedure and performing provider’s unique physician identification number.

Results showed 93.4 percent sensitivity and 97.8 percent specificity for claims for colon polyps. Claims for other GI diagnoses, including colorectal tumors and incomplete colonoscopy, showed “suboptimal” sensitivity.

Read the study about Medicare claims for GI diagnoses.

Read other coverage about GI quality:

ASGE New Initiative Issues Report on Diminutive Colorectal Polyps

Conversion Factor Can Be Used to Estimate Adenoma Detection Rate From Polyp Detection Rate

Baylor Health, Eureka Form Alliance for Colorectal Cancer Research

Advertisement

Next Up in GI & Endoscopy

  • Renton, Wash.-based Providence has re-opened its North Coast Surgery Center in Oceanside, Calif., the Times Standard reported Feb. 5.  The…

  • Gastroenterology is rapidly transforming as health systems invest in outpatient digestive care, private equity-backed platforms expand and new technology reshapes…

  • AI’s early gains in gastroenterology are showing up in some of the most workflow-heavy parts of endoscopy — polyp detection,…

Advertisement

Comments are closed.